TX-001HR is associated with a clinically meaningful effect on severity of moderate to severe vasomotor symptoms in the REPLENISH trial

OBJECTIVE: The aim of the study was to evaluate the clinically meaningful effect of oral TX-001HR (17β-estradiol [E2]/progesterone [P4]) capsules on hot flushes severity (vasomotor symptoms [VMS] severity scale) using the patient-reported Clinical Global Impression (CGI). METHODS: REPLENISH (NCT0194...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Menopause
Main Authors: Constantine, Ginger D., Simon, James A., Kaunitz, Andrew M., Pickar, James H., Revicki, Dennis A., Graham, Shelli, Bernick, Brian, Mirkin, Sebastian
Formato: Artigo
Idioma:Inglês
Publicado em: Lippincott Williams & Wilkins 2020
Assuntos:
Original Studies
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7587237/
https://ncbi.nlm.nih.gov/pubmed/33110039
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/GME.0000000000001602
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados